BCM
OCGN icon

Bayesian Capital Management’s Ocugen OCGN Stock Holding History

Bayesian Capital Management’s Portfolio OCGN Stock Details OCGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-47,700
Closed -$19.1K – 954
2023
Q3 		$19.1K Buy
+47,700
New +$23.5K ﹤0.01% 653
2023
Q1 		– Sell
-33,544
Closed -$43.6K – 1007
2022
Q4 		$43.6K Buy
33,544
+10,544
+46% +$16.4K 0.01% 710
2022
Q3 		$41K Buy
+23,000
New +$57.3K 0.01% 631

Other funds holding OCGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LM
Luminus Management Houston, Texas $166M AUM 75.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Bayesian Capital Management's OCGN Position: Q4 2023 in Review

Bayesian Capital Management sold out of Ocugen (OCGN) in Q4 2023, closing a stake of 47,700 shares — an estimated $19.1K sold.

Bayesian Capital Management first reported a position in OCGN in Q3 2022 and held it in 3 quarters. The position peaked at $43.6K in Q4 2022. 68 funds tracked by Wall St. Rank hold OCGN as of Q4 2023.

  • Bayesian Capital Management reported no remaining Ocugen position as of Q4 2023 after selling out during the quarter.
  • Bayesian Capital Management sold 47,700 Ocugen shares in Q4 2023, an estimated $19.1K.
  • Bayesian Capital Management first reported a position in Ocugen in Q3 2022 and held it in 3 quarters.
  • Bayesian Capital Management's Ocugen position peaked at $43.6K in Q4 2022.
  • 68 funds tracked by Wall St. Rank held Ocugen as of Q4 2023.

Based on Bayesian Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.